“Just as medicine has its own language, so does business," two surgeons explained in a new editorial. 

The Aventus Thrombectomy System was already cleared to treat blood clots in the peripheral arteries. This latest approval comes after positive results from an IDE study were published in JSCAI.

American College of Cardiology Board of Governors Chair David E. Winchester, MD, MS, examines the many benefits of working with the American Medical Association House of Delegates to bring about significant change.

An exclusive interview with Hal Andrews, President and CEO of Trilliant Health, on the topic of price transparency and how regulators and companies can contain costs for patients. 

The American Medical Association passed a resolution at its recent annual meeting seeking to “maximize trust” around how these models reach conclusions. 
 

Subsidiary RayzeBio has inked a definitive deal to license the worldwide rights for the drug from Philochem, a Swiss biotechnology firm. 

Faranak Firozan, 47, is a cybersecurity expert at Nvidia who regularly spoke on the topic of “cyber laundering.” Prosecutors in California allege she submitted fraudulent medical claims to an employer-sponsored insurance plan, bilking Cigna out of $100,000.

Sixty-one-year-old Lilit Gagikovna Baltaian, MD, is on the run after being convicted of fraudulently billing Medicare alongside co-conspirators at home health agencies. A federal court in California sentenced her to 54 months in prison.